Median Technologies

Median Technologies company information, Employees & Contact Information

Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. We harness the power of medical images by using the most advanced Artificial Intelligence technologies, to increase the accuracy of diagnosis and treatment of many cancers and other metabolic diseases at their earliest stages and provide insights into novel therapies for patients. Our iCRO solutions for medical image analysis and management in oncology trials and eyonis™, our AI/ML tech-based suite of software as medical devices (SaMD) help biopharmaceutical companies and clinicians to bring new treatments and diagnose patients earlier and more accurately. This is how we are helping to create a healthier world. Founded in 2002, based in Sophia-Antipolis, France, with a subsidiary in the US and another one in Shanghai, Median has received the label “Innovative company” by the BPI and is listed on Euronext Growth market (Paris). FR0011049824– ticker: ALMDT. Median is eligible for the French SME equity savings plan scheme (PEA-PME).
Looking for a particular Median Technologies employee's phone or email?

Median Technologies Questions

News

Median Technologies Reports First-Half 2025 Financial Results and Provides Key Q3 2025 Business Results - Yahoo Finance

Median Technologies Reports First-Half 2025 Financial Results and Provides Key Q3 2025 Business Results Yahoo Finance

Median Technologies Business Update Following Successful Financing - Business Wire

Median Technologies Business Update Following Successful Financing Business Wire

Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders’ Ordinary and Extraordinary General Meeting on October 31, 2025 - Yahoo Finance

Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders’ Ordinary and Extraordinary General Meeting on October 31, 2025 Yahoo Finance

BROADPEAK SA: Disclosure of total number of voting rights and number of shares in the capital as of September 30, 2025 - TradingView

BROADPEAK SA: Disclosure of total number of voting rights and number of shares in the capital as of September 30, 2025 TradingView

Median Technologies Receives €19 Million From the European Investment Bank, Corresponding to the First Tranche Under the 2025 Loan Facility - Silicon Canals

Median Technologies Receives €19 Million From the European Investment Bank, Corresponding to the First Tranche Under the 2025 Loan Facility Silicon Canals

Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of August 31, 2025 - Business Wire

Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of August 31, 2025 Business Wire

Median Technologies Has Completed a Capital Increase of € 23.9 Million - Business Wire

Median Technologies Has Completed a Capital Increase of € 23.9 Million Business Wire

Median Technologies: H2 2025 Financial Communication Calendar - Yahoo Finance

Median Technologies: H2 2025 Financial Communication Calendar Yahoo Finance

Median Technologies Reports 2025 Q1 Key Financial Indicators and Provides an Update on Q1 Key Operational Achievements - Business Wire

Median Technologies Reports 2025 Q1 Key Financial Indicators and Provides an Update on Q1 Key Operational Achievements Business Wire

Median Technologies Announces the Drawdown of €8.5m Corresponding to the Final Tranche of the European Investment Bank Loan - The AI Journal

Median Technologies Announces the Drawdown of €8.5m Corresponding to the Final Tranche of the European Investment Bank Loan The AI Journal

Median Technologies Signs Financial Agreement for up to €37.5 Million New Financing Facility With the European Investment Bank (EIB) - Yahoo Finance

Median Technologies Signs Financial Agreement for up to €37.5 Million New Financing Facility With the European Investment Bank (EIB) Yahoo Finance

Median Technologies Reports Full-year 2024 Financial Results - Business Wire

Median Technologies Reports Full-year 2024 Financial Results Business Wire

Median Technologies to Showcase Its Artificial Intelligence Software as a Medical Device for Lung Cancer Screening, eyonis™ LCS, at the European Congress of Radiology - Business Wire

Median Technologies to Showcase Its Artificial Intelligence Software as a Medical Device for Lung Cancer Screening, eyonis™ LCS, at the European Congress of Radiology Business Wire

Following the Signature of a Financial Agreement for up to €37.5 Million With the EIB, Median Technologies Launches an Approximately €22.0 Million Capital Increase to Support Commercialization of eyonis® LCS in the U.S. and to Finance Expansion ... - Business Wire

Following the Signature of a Financial Agreement for up to €37.5 Million With the EIB, Median Technologies Launches an Approximately €22.0 Million Capital Increase to Support Commercialization of eyonis® LCS in the U.S. and to Finance Expansion ... Business Wire

Median Technologies Announces Rebranding of iBiopsy®, Changes Name to eyonis™ - Business Wire

Median Technologies Announces Rebranding of iBiopsy®, Changes Name to eyonis™ Business Wire

Assessing immunotherapy response: going beyond RECIST by integrating early tumor growth kinetics - Frontiers

Assessing immunotherapy response: going beyond RECIST by integrating early tumor growth kinetics Frontiers

Median Technologies launches Imaging Lab - Imaging Technology News

Median Technologies launches Imaging Lab Imaging Technology News

Median Technologies Is Moving Forward With the FDA Interactions for Its iBiopsy Lung Cancer Screening CADe/CADx Software as Medical Device - Imaging Technology News

Median Technologies Is Moving Forward With the FDA Interactions for Its iBiopsy Lung Cancer Screening CADe/CADx Software as Medical Device Imaging Technology News

Median Technologies Announces Performance for Its iBiopsy Lung Cancer Screening CADx With a Focus on Stage 1 Lung Cancer Characterization - Imaging Technology News

Median Technologies Announces Performance for Its iBiopsy Lung Cancer Screening CADx With a Focus on Stage 1 Lung Cancer Characterization Imaging Technology News

iBiopsy® for Precision Medicine - European Medical Journal

iBiopsy® for Precision Medicine European Medical Journal

Top Median Technologies Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant